Abstract
BackgroundIn our institutions, there are two types of stents used: the Boston Scientific Wallflex (Marlborough, Massachusetts) and Merit Medical Endotek (South Jordan, Utah). So we performed this retrospective study to compare complication rates in various esophageal disorders to improve our quality of care.MethodsCharts were reviewed to capture gender, indications of stent placement, stent length/diameter, age of the patient at the time of stent placement, length of hospital stay, physicians performing a procedure, and complications within 90 days of stent placement.ResultsA total of 67 patients (71.6% male) underwent stent placement (WallFlex 49.3% and Merit 50.8%) for malignant (68.7%) mainly esophageal obstruction by primary esophageal cancer (89.1%) and benign causes (31.3%) mainly esophageal leak (66.7%). Merit and WallFlex used in malignant conditions were 82.4% and 54.6%, respectively, and in benign conditions, they were 17.7% and 45.5%, respectively. The mean age at which endoscopy was performed was 64. Complications post Merit and WallFlex placement were 79.4% and 60.6%, respectively. Complications with malignant and benign conditions were 73.9% and 61.9%, respectively. Complications with 19, 18, and 23 mm diameters were 75.0%, 66.7%, and 69.4%, respectively. Complications with 120, 150, 100, 15, 12, 10 mm stent lengths were 84.6%, 58.3%, 58.8%, 80.0%, 75.0%, and 33.3%, respectively.ConclusionOur study showed that the Merit stent was mainly used, and the major indication of stent placement was a malignant condition. Major complications were seen when the reason for stent placement was a malignant condition, the diameter was 19 mm, the length was 120 mm, and the use of the Merit stent.
Highlights
An esophageal stent is a minimally invasive procedure that is often used in benign esophageal disorders, such as esophageal leaks, fistulas, refractory strictures, and malignant conditions, such as locally unresectable or advanced metastatic cancer of the esophagus, those with poor functional status who can’t tolerate surgery or chemoradiotherapy, or those in whom previous treatment failed or those with locally recurrent disease [1].There are numerous treatment options for malignant and benign esophageal conditions like surgical resection, photodynamic therapy, thermal ablative therapy, chemotherapy-radiation therapy, and esophageal stent
Merit and WallFlex used in malignant conditions were 82.4% and 54.6%, respectively, and in benign conditions, they were 17.7% and 45.5%, respectively
Our study showed that the Merit stent was mainly used, and the major indication of stent placement was a malignant condition
Summary
An esophageal stent is a minimally invasive procedure that is often used in benign esophageal disorders, such as esophageal leaks, fistulas, refractory strictures, and malignant conditions, such as locally unresectable or advanced metastatic cancer of the esophagus, those with poor functional status who can’t tolerate surgery or chemoradiotherapy, or those in whom previous treatment failed or those with locally recurrent disease [1].There are numerous treatment options for malignant and benign esophageal conditions like surgical resection, photodynamic therapy, thermal ablative therapy, chemotherapy-radiation therapy, and esophageal stent. Esophageal stents that are mostly used in the U.S include Boston Scientific (Marlborough, Massachusetts), Cook Medical (Bloomington, Indiana), EndoChoice (Alpharetta, Georgia), Merit Medical Endotek (South Jordan, Utah), and Taewoong Medical Co (Seoul, Korea). There are two types of stents used: the Boston Scientific Wallflex (Marlborough, Massachusetts) and Merit Medical Endotek (South Jordan, Utah). We performed this retrospective study to compare complication rates in various esophageal disorders to improve our quality of care
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
